Molecular Diagnostics Market Research Report
The clinical laboratory, molecular diagnostics has become indispensable. This includes all methods and tests for the identification of a disease and comprehending the predisposition for a disease by analyzing DNA or RNA of an organism. The rapid advances in molecular diagnostics have significantly enabled basic research and results in practical diagnosis.
The clinical laboratory, molecular diagnostics has become indispensable. This includes all methods and tests for the identification of a disease and comprehending the predisposition for a disease by analyzing DNA or RNA of an organism. The rapid advances in molecular diagnostics have significantly enabled basic research and results in practical diagnosis.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
List of Figures<br />
24. <strong>Market</strong> Share Analysis for the Global <strong>Molecular</strong><br />
<strong>Diagnostics</strong> <strong>Market</strong>, 2016<br />
25. <strong>Market</strong> Share Analysis for the Global <strong>Molecular</strong><br />
<strong>Diagnostics</strong> <strong>Market</strong>, 2017<br />
26. Growth Share Matrix (Opportunity Mapping Matrix)<br />
for Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by<br />
companies), 2016<br />
27. Growth Share Matrix (Opportunity Mapping Matrix)<br />
for Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by<br />
companies), 2017<br />
28. Overall Industry Attractiveness, 2018 and 2028<br />
29. Overall Impact of Bargaining Power of Suppliers<br />
30. Overall Impact of Bargaining Power of Buyers<br />
31. Overall Impact of Threat of New Entrants<br />
32. Overall Impact of Threat of Substitute Products<br />
33. Overall Impact of Intensity of Competitive Rivalry<br />
34. Components Considered for Clinical Evidence as<br />
per the IVDR<br />
35. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Product)<br />
36. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Product),<br />
2017 and 2028<br />
37. General Workflow of a <strong>Molecular</strong> Diagnostic Kit<br />
38. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Kits and<br />
Consumables), 2017-2028<br />
39. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Systems),<br />
2017-2028<br />
40. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Systems,<br />
by Type), 2017-2028<br />
41. Aspects of Software Development<br />
42. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Software<br />
and Other Products), 2017-2028<br />
43. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Application)<br />
44. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by<br />
Application), 2017<br />
45. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by<br />
Application), 2028<br />
46. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Core MDx<br />
Applications), 2017 and 2028<br />
47. Nucleic Acid Testing Techniques for Infectious<br />
Diseases<br />
48. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Infectious<br />
Diseases), 2017-2028<br />
49. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Infectious<br />
Diseases), 2017 and 2028<br />
50. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Infectious<br />
Diseases, by Technology), 2017 and 2028<br />
51. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Genetic<br />
Testing), 2017-2028<br />
52. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Genetic<br />
Testing, by Technology), 2017 and 2028<br />
53. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Blood<br />
Donor Screening), 2017-2028<br />
54. Clinical Uses of <strong>Molecular</strong> <strong>Diagnostics</strong> in Cancer<br />
55. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Cancer),<br />
2017-2028<br />
56. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Oncology),<br />
2017 and 2028<br />
57. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Oncology,<br />
by Technology), 2017 and 2028<br />
58. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by HLA<br />
Testing), 2017-2028<br />
59. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Other<br />
Applications), 2017-2028<br />
60. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Companion<br />
<strong>Diagnostics</strong>), 2017 and 2028<br />
61. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by NIPT, by<br />
Technology), 2017 and 2028<br />
62. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Companion<br />
<strong>Diagnostics</strong>), 2017 and 2028<br />
63. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Companion<br />
<strong>Diagnostics</strong>, by Technology), 2017 and 2028<br />
64. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Liquid<br />
Biopsy), 2017 and 2028<br />
65. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by Liquid<br />
Biopsy, by Technology), 2017 and 2028<br />
66. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by<br />
Technology)<br />
67. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by<br />
Technology), 2017<br />
68. Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> (by PCR),<br />
2017-2028<br />
sales@bisresearch.com | www.bisresearch.com
Change language